Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M56,379Revenue $M104,099Net Margin (%)1.9Z-Score3.1
Enterprise Value $M70,242EPS $2.3Operating Margin %3.5F-Score6
P/E(ttm))30.8Cash Flow Per Share $3.6Pre-tax Margin (%)3.0Higher ROA y-yY
Price/Book2.810-y EBITDA Growth Rate %25.9Quick Ratio0.5Cash flow > EarningsY
Price/Sales0.65-y EBITDA Growth Rate %24.3Current Ratio0.6Lower Leverage y-yY
Price/Cash Flow14.9y-y EBITDA Growth Rate %2.0ROA % (ttm)3.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)8.9Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M745ROI % (ttm)3.5Gross Margin Increase y-yN

Gurus Latest Trades with ESRX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ESRXGlenn Greenberg 2014-06-30 Add3.17%$66.17 - $76.08
($70.4)
$ 76.829%Add 31.94%4,678,694
ESRXCharles Brandes 2014-06-30 Buy 1.8%$66.17 - $76.08
($70.4)
$ 76.829%New holding, 2102152 sh.2,102,152
ESRXWallace Weitz 2014-06-30 Add1.1%$66.17 - $76.08
($70.4)
$ 76.829%Add 43.89%1,742,324
ESRXDodge & Cox 2014-06-30 Add0.42%$66.17 - $76.08
($70.4)
$ 76.829%Add 54.28%17,874,930
ESRXJoel Greenblatt 2014-06-30 Add0.17%$66.17 - $76.08
($70.4)
$ 76.829%Add 682.51%218,877
ESRXHOTCHKIS & WILEY 2014-06-30 Add0.16%$66.17 - $76.08
($70.4)
$ 76.829%Add 50.52%1,918,200
ESRXKen Fisher 2014-06-30 Add0.04%$66.17 - $76.08
($70.4)
$ 76.829%Add 75.84%593,431
ESRXScott Black 2014-06-30 Reduce-0.32%$66.17 - $76.08
($70.4)
$ 76.829%Reduce -22.86%129,139
ESRXLeon Cooperman 2014-06-30 Sold Out -0.14%$66.17 - $76.08
($70.4)
$ 76.829%Sold Out0
ESRXChris Davis 2014-06-30 Reduce-0.14%$66.17 - $76.08
($70.4)
$ 76.829%Reduce -5.95%10,703,208
ESRXRay Dalio 2014-06-30 Reduce-0.04%$66.17 - $76.08
($70.4)
$ 76.829%Reduce -62.3%37,654
ESRXVanguard Health Care Fund 2014-03-31 Buy 0.69%$69.84 - $78.64
($74.72)
$ 76.823%New holding, 3265000 sh.3,265,000
ESRXDodge & Cox 2014-03-31 Add0.46%$69.84 - $78.64
($74.73)
$ 76.823%Add 106.54%11,586,300
ESRXMario Gabelli 2014-03-31 Add0.05%$69.84 - $78.64
($74.73)
$ 76.823%Add 60.44%316,403
ESRXGlenn Greenberg 2014-03-31 Reduce-1.19%$69.84 - $78.64
($74.73)
$ 76.823%Reduce -10.42%3,546,006
ESRXChris Davis 2014-03-31 Reduce-0.25%$69.84 - $78.64
($74.73)
$ 76.823%Reduce -11.59%11,380,532
ESRXKen Fisher 2014-03-31 Reduce-0.04%$69.84 - $78.64
($74.72)
$ 76.823%Reduce -45.24%337,475
ESRXRay Dalio 2014-03-31 Reduce-0.02%$69.84 - $78.64
($74.73)
$ 76.823%Reduce -30%99,888
ESRXGlenn Greenberg 2013-12-31 Add1.67%$60.88 - $70.6
($65.26)
$ 76.8218%Add 17.2%3,958,387
ESRXScott Black 2013-12-31 Add0.74%$60.88 - $70.6
($65.26)
$ 76.8218%Add 130.81%173,883
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ESRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ESRX Vanguard Health Care Fund 2014-09-303,621,2000.490.65+10.91%
ESRX Charles Brandes 2014-06-302,102,1520.281.8New Buy
ESRX Joel Greenblatt 2014-06-30218,8770.030.19+682.51%
ESRX Ken Fisher 2014-06-30593,4310.080.09+75.84%
ESRX Dodge & Cox 2014-06-3017,874,9302.41.2+54.28%
ESRX HOTCHKIS & WILEY 2014-06-301,918,2000.260.47+50.52%
ESRX Wallace Weitz 2014-06-301,742,3240.233.6+43.89%
ESRX Glenn Greenberg 2014-06-304,678,6940.6313.1+31.94%
ESRX Mario Gabelli 2014-06-30365,9390.050.13+15.66%
ESRX Vanguard Health Care Fund 2014-06-303,265,0000.440.6
ESRX Jean-Marie Eveillard 2014-06-301,16800
ESRX John Keeley 2014-06-3030,95800.04-5.84%
ESRX Chris Davis 2014-06-3010,703,2081.442.2-5.95%
ESRX Ruane Cunniff 2014-06-305,03100-11.03%
ESRX Scott Black 2014-06-30129,1390.021.3-22.86%
ESRX Ray Dalio 2014-06-3037,6540.010.02-62.3%
ESRX Leon Cooperman 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


ESRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
IGNACZAK EDWARD BEVP 2014-09-05Sell9,886$75.282.18view
STERNBERG SEYMOURDirector 2014-08-28Sell15,508$74.123.78view
Ebling Keith J.Exec. VP and General Counsel 2014-08-25Sell10,000$75.51.88view
BENANAV GARY GDirector 2014-08-05Sell12,694$70.828.61view
Wade Sara ESr. VP, Ch. Human Res. Off. 2014-08-05Sell20,000$70.449.2view
Norton David ASenior VP, Supply Chain 2014-08-04Sell1,276$71.028.31view
Breen Maura CDirector 2014-08-01Sell12,694$69.949.98view
PAZ GEORGEChairman & CEO 2014-06-13Sell681,508$71.218.02view
WENTWORTH TIMOTHY CPresident 2014-05-27Sell105,677$70.479.15view
Wimberly GarySr. VP & Ch. Information Off. 2014-03-13Sell44,497$78.41-1.9view

Press Releases about ESRX :

    Quarterly/Annual Reports about ESRX:

    News about ESRX:

    Articles On GuruFocus.com
    Why The Diplomat Pharmacy IPO Could Rock The Industry Oct 12 2014 
    Wallace Weitz's Partners Value Fund Q2 Commentary Oct 06 2014 
    Wallace Weitz's Value Fund Q2 Commentary Oct 06 2014 
    Is Walgreen Set For A Better 2014? Jul 28 2014 
    Dodge & Cox Second Quarter 2014 Commentary Jul 23 2014 
    David Rolfe's Wedgewood Partners Q2 2014 Commentary Jul 15 2014 
    Weekly CEO Sells Highlight: Installed Building Products Inc, Express Scripts, Adobe Systems Inc, and Jun 22 2014 
    Wedgewood Partners' David Rolfe's Top Five Stocks May 28 2014 
    Weekly Insider Sells Highlight: JAZZ, HD, ESRX, SCI Mar 11 2014 
    It's Time to Follow Chris Davis and Buy Laboratory Corp Jan 15 2014 


    More From Other Websites
    Express Scripts Well Positioned for New Health-Care Order Oct 31 2014
    Midday Glance: Drug Benefits companies Oct 30 2014
    Early Glance: Drug Benefits companies Oct 30 2014
    Final Glance: Drug Benefits companies Oct 29 2014
    Express Scripts Reports In-Line Q3 Earnings, Narrows View Oct 29 2014
    Express Scripts says AbbVie drug could displace Sovaldi on formulary Oct 29 2014
    Stocks Flat Ahead of Fed Oct 29 2014
    Express Scripts Holding Co Earnings Call scheduled for 8:30 am ET today Oct 29 2014
    [$$] Express Scripts Profit Rise Oct 28 2014
    Express Scripts meets 3Q profit forecasts Oct 28 2014
    Express Scripts meets 3Q profit forecasts Oct 28 2014
    After-hours buzz: Express Scripts, Facebook & more Oct 28 2014
    Express Scripts Announces 3rd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point Oct 28 2014
    Earnings roundup: FB, EA, GILD, INVN & ESRX Oct 28 2014
    EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Oct 28 2014
    Express Scripts Announces 3rd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point Oct 28 2014
    3 Health Services Stocks Pushing The Industry Higher Oct 28 2014
    Sanofi Stuns Investors as U.S. Price Pressure Bites Oct 28 2014
    Q3 2014 Express Scripts Holding Co Earnings Release - After Market Close Oct 28 2014
    Will DENTSPLY (XRAY) Disappoint Earnings this Season? Oct 27 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    Srichardson
    ReplySrichardson - 2 months ago
    How do you see the % of Total Asset for a position in a guru portfolio?
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK